37076-68-9; (R)-Tegafur; (R)-Ftorafur; Tegafur, (R)-; 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-; 5-fluoro-1-[(2R)-oxolan-2-yl]pyrimidine-2,4-dione; CHEMBL235993; DTXSID8021305; NSC148958; NSC-200695; 5317337V7V; DTXCID801436391; 5-fluoro-1-[(2R)-oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione; CAS-37076-68-9; Ftorafur, (R)-; 2,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-; UNII-5317337V7V; NCGC00159418-02; NCGC00159418-05; R-1-(Tetrahydrofuran-2-yl)-5-fluorouracil; 2-Cyclohexene-1-one??; NCIMech_000223; SCHEMBL4553; Uracil, 5-fluoro-1-(tetrahydro-2-furyl)-, (R)-; ZINC119895; Tox21_111649; Tox21_301812; BDBM50247894; CCG-35341; CCG-36092; NSC200695; s1300; AKOS024306980; Tox21_111649_1; NCGC00255222-01; NCGC00386138-01; BT166256; NCI60_001026; Tegafur (FT-207, NSC 148958); F0635; SW220241-1; 5-Fluoro-1-[(R)-tetrahydrofuran-2-yl]uracil; AB01566812_01; EN300-8676918; A823522; 5-fluoro-1-[(2R)-2-oxolanyl]pyrimidine-2,4-dione; Q27261036; 5-fluoranyl-1-[(2R)-oxolan-2-yl]pyrimidine-2,4-dione; 5-fluoro-1-(R)-tetrahydro-furan-2-yl-1H-pyrimidine-2,4-dione, AldrichCPR